Dr. Vaidya on Advances in the Management of Endometrial Cancer


In Partnership With:

Ami P. Vaidya, MD, discusses advances in the management of endometrial cancer.

Ami P. Vaidya, MD, vice chair, Department of Obstetrics and Gynecology, co-chief, Division of Gynecologic Oncology, director, Robotics, Gynecology, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack Meridian Health, discusses advances in the management of endometrial cancer.

The integration of minimally invasive surgery into the treatment paradigm of endometrial cancer has significantly decreased postoperative healing time for patients, Vaidya says. Additionally, patient testimonials, as well as clinical data, have demonstrated that minimally invasive surgery decreases postoperative pain, decreases time spent in the hospital, and shortens recovery time overall.

Sentinel lymph node biopsy has also been a significant advancement in the field of endometrial cancer. Long-term data are beginning to show decreased rates of lymphedema on the order of 5% vs 30% in patients who underwent sentinel lymph node identification, Vaidya concludes.

Related Videos
Jeffrey Zonder, MD
Jun Gong, MD
John Michael Bryant, MD,
Chandler H. Park, MD, FACP
Kathryn Beckermann, MD, PhD
Eleonora Dondossola, PhD
William B. Pearse, MD
Pasi A. Jänne, MD, PhD, director, Lowe Center for Thoracic Oncology, director, Belfer Center for Applied Cancer Science, director, Chen-Huang Center for EGFR Mutant Lung Cancers, senior physician, David M. Livingston, MD, Chair, Dana-Farber Cancer Institute; professor, medicine, Harvard Medical School
Rachid Baz, MD, section head, Myeloma, Department of Malignant Hematology, Moffitt Cancer Center; co-director, Pentecost Family Myeloma Research Center
Harriet Kluger, MD, Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; director, Yale SPORE in Skin Cancer; vice chair, Translational Research, Internal Medicine; chief, Division of Skin and Kidney Cancer; associate cancer center director, Education, Training and Faculty Development; deputy section chief, Medical Oncology, Yale Cancer Center